Rosen Quoted in Inside Health Policy About DeLaura, Bishop Relationship and FDA Spending Decisions
December 10, 2020
Inside Health Policy
Partner David Rosen was quoted in the Inside Health Policy article, “DeLauro, Bishop Relationship Could Enhance FDA Approps,” about how incoming House Appropriations Committee Chair Rosa DeLauro (D-CT) could play a key role in FDA-related spending decisions due to her close dealings with Rep. Sanford Bishop (D-GA), who heads the FDA appropriations subcommittee that DeLauro has previously chaired.
Rosen told IHP that DeLauro’s interest in increasing access to medical products and engagement in the FDA regulatory process will make her a good committee chair.
(Subscription required.)
People
Related News
May 20, 2026
In the News
Scott Johnson Interviewed on Expanded DPA Use to Support Domestic Energy Supply Chains
Foley & Lardner LLP of counsel Scott Johnson appeared on Federal News Network to discuss presidential determinations under the Defense Production Act (DPA).
May 18, 2026
In the News
Judith Waltz Assesses CMS Moratoria and Enforcement Impact
Foley & Lardner LLP Judith Waltz analyzed the impact of new recent federal enforcement actions on home health agencies (HHAs) and hospices in the Report on Medicare Compliance article, “Site Visits Surge for Home Health, Hospice Providers; CMS Implements Enrollment Moratoria.”
May 15, 2026
In the News
Scott Ellis on New SEC Reporting Plan and Implications for the Energy Sector
Foley & Lardner LLP partner Scott Ellis spoke to Law360 for the article, “New SEC Reporting Plan May Not Sway Energy Cos.,” discussing the U.S. Securities and Exchange Commission’s proposed shift from a quarterly to a semiannual earnings reporting schedule for public companies.